Deutsche Bank’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.55M | Sell |
262,957
-934,731
| -78% | -$30.4M | ﹤0.01% | 1042 |
|
|
2025
Q1 | $45.2M | Sell |
1,197,688
-15,018
| -1% | -$567K | 0.02% | 642 |
|
|
2024
Q4 | $99.3M | Buy |
1,212,706
+64,522
| +6% | +$5.28M | 0.04% | 432 |
|
|
2024
Q3 | $131M | Buy |
1,148,184
+1,018,122
| +783% | +$116M | 0.05% | 330 |
|
|
2024
Q2 | $9.82M | Sell |
130,062
-6,086
| -4% | -$460K | ﹤0.01% | 1006 |
|
|
2024
Q1 | $9.3M | Sell |
136,148
-16,110
| -11% | -$1.1M | ﹤0.01% | 1042 |
|
|
2023
Q4 | $9.56M | Buy |
152,258
+77,179
| +103% | +$4.85M | ﹤0.01% | 1012 |
|
|
2023
Q3 | $3.83M | Buy |
75,079
+32,099
| +75% | +$1.64M | ﹤0.01% | 1104 |
|
|
2023
Q2 | $2.15M | Sell |
42,980
-6,549
| -13% | -$327K | ﹤0.01% | 1586 |
|
|
2023
Q1 | $1.86M | Buy |
49,529
+14,034
| +40% | +$526K | ﹤0.01% | 1726 |
|
|
2022
Q4 | $1.7M | Buy |
35,495
+11,668
| +49% | +$559K | ﹤0.01% | 1745 |
|
|
2022
Q3 | $572K | Sell |
23,827
-2,664
| -10% | -$64K | ﹤0.01% | 2291 |
|
|
2022
Q2 | $576K | Buy |
26,491
+2,205
| +9% | +$47.9K | ﹤0.01% | 2493 |
|
|
2022
Q1 | $587K | Sell |
24,286
-5,758
| -19% | -$139K | ﹤0.01% | 2639 |
|
|
2021
Q4 | $714K | Buy |
30,044
+1,368
| +5% | +$32.5K | ﹤0.01% | 2605 |
|
|
2021
Q3 | $727K | Sell |
28,676
-1,029
| -3% | -$26.1K | ﹤0.01% | 2796 |
|
|
2021
Q2 | $668K | Buy |
29,705
+10,545
| +55% | +$237K | ﹤0.01% | 3024 |
|
|
2021
Q1 | $378K | Buy |
19,160
+5,378
| +39% | +$106K | ﹤0.01% | 3254 |
|
|
2020
Q4 | $366K | Buy |
13,782
+4,045
| +42% | +$107K | ﹤0.01% | 3088 |
|
|
2020
Q3 | $481K | Buy |
+9,737
| New | +$481K | ﹤0.01% | 2637 |
|